University of Washington School of Pharmacy

What University of Washington School of Pharmacy does

The University of Washington School of Pharmacy is an academic unit within the University of Washington public research university, founded in 1899 and headquartered in Seattle, Washington. It educates pharmacists and pharmaceutical scientists through a portfolio of degree programs including the PharmD, PhD programs in Medicinal Chemistry, Pharmaceutics, and Health Economics & Outcomes Research, an MS in Biomedical Regulatory Affairs (BRAMS), and a PharmD-MBA dual degree. It also operates the Rubenstein Pharmacy for clinical training and core research service facilities including the Mass Spectrometry Center and Bioanalysis and Pharmacokinetics Lab.

The school is organized across three departments — Medicinal Chemistry, Pharmaceutics, and Pharmacy — and a network of specialized research centers covering health economics and outcomes (CHOICE Institute), geriatric pharmacy (Plein Center for Aging), epilepsy drug discovery (CEDD), long-acting HIV therapeutics (TLC-ART), obstetric-fetal pharmacology (OPRU), drug design and metabolism (DMTSPR), and the newly launched Institute for Innovations in Drug Disposition and Delivery (I2D3). Its research capabilities span drug design, metabolism and transport, pharmacokinetics, microphysiological organ systems, and real-world evidence generation.

The school does not operate as a commercial entity and revenue is not publicly disclosed; its funding is sourced from state appropriations, tuition, federal research grants (notably NIH), and philanthropic donations managed by its Office of Advancement. Its primary customers are prospective PharmD students, PhD and MS candidates, biomedical regulatory affairs professionals, and practicing pharmacists served through continuing-education partnerships with the Washington State Pharmacy Association.

Name

University of Washington School of Pharmacy

Legal name

University of Washington

Website

https://sop.washington.edu

Company type

Private

Founded year

1899

Operating status

Operating

Headcount range

101–250 employees

Short description

The University of Washington School of Pharmacy is a public academic unit that educates pharmacists and pharmaceutical scientists via PharmD, PhD, and MS programs. It conducts drug discovery, pharmacokinetics, and health economics research, serving students, the pharmacy profession, and the Pacific Northwest healthcare ecosystem.

Ownership category

akta.pro rank

Product category

Pharmacy Education

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Colleges, Universities, and Professional Schools (61131), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Educational Services (8200), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYEDAHAGAE

Schools of Pharmacy

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYEDAHAGAO

Schools of Medical Laboratory Science & Clinical Diagnostics

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

Keywords

• Pharmacy education
• Pharmaceutical research
• Drug discovery
• Clinical pharmacy
• Health economics research

Headquarters

HQ city

Seattle, Washington

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Distribution channels4 records

Marketing channels8 records

Core offering

University of Washington School of Pharmacy is an academic institution that educates future pharmacists and pharmaceutical scientists through Doctor of Pharmacy (PharmD), PhD, and MS degree programs, while conducting translational research in drug discovery, pharmacokinetics, drug metabolism, and health economics. The school delivers research services through specialized core facilities and supports pharmacy practice innovation via clinical partnerships and continuing education.

Product overview

University of Washington School of Pharmacy is an academic institution offering a portfolio of educational programs and research services. The core offering is the PharmD program, complemented by doctoral programs (PhD in Medicinal Chemistry, Pharmaceutics, and Health Economics & Outcomes Research), the MS in Biomedical Regulatory Affairs, and a PharmD-MBA dual degree. Research services include the Mass Spectrometry Center, Bioanalysis and Pharmacokinetics Lab, and Rubenstein Pharmacy for clinical training. The school operates through three academic departments (Medicinal Chemistry, Pharmaceutics, Pharmacy) and multiple specialized research centers including The CHOICE Institute, Plein Center for Aging, and the Center for Epilepsy Drug Discovery.

Differentiator

Problem solved

Functional benefit

Products and services

• PharmD Program Doctor of Pharmacy professional degree program providing comprehensive education in pharmaceutical sciences, clinical pharmacy practice, and patient care for students pursuing licensure as pharmacists.
• Medicinal Chemistry Graduate Program (PhD) Doctoral program focused on drug design, metabolism, and chemical biology research for students pursuing research careers in medicinal chemistry.
• Pharmaceutics Graduate Program (PhD) Doctoral program covering drug delivery, pharmacokinetics, and formulation sciences for students pursuing research careers in pharmaceutics.
• PhD in Health Economics & Outcomes Research Doctoral program offered through The CHOICE Institute focusing on health economics, policy, and pharmaceutical outcomes research.
• PharmD-MBA Dual Degree Combined Doctor of Pharmacy and Master of Business Administration program for students seeking both pharmaceutical leadership and management expertise.
• MS in Biomedical Regulatory Affairs (BRAMS) Master's program preparing professionals for careers in regulatory affairs, compliance, and drug approval processes within the biomedical industry.
• Rubenstein Pharmacy On-site clinical pharmacy providing patient care services and serving as an experiential learning site for pharmacy students.
• Mass Spectrometry Center Core research facility providing mass spectrometry services for drug analysis and metabolomics research to academic and industry users.
• Bioanalysis and Pharmacokinetics Lab Laboratory service providing bioanalytical method development and pharmacokinetic modeling and simulation for research collaborators.
• Performance Based Risk Sharing Database Research resource providing data on performance-based risk sharing arrangements in healthcare for researchers studying pharmaceutical policy and outcomes.
• Institute for Innovations in Drug Disposition and Delivery (I2D3) Newly launched research institute within the School of Pharmacy dedicated to innovations in drug disposition and delivery, supporting faculty research and translation.

Quantifiable outcome

• Pharmacy programs ranked among highest ROI graduate degrees nationally
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and secondary.

• Gilead SciencescoreStrategic or Co-development PartnerPartnership through affiliate faculty appointments - Maria Agapova serves as Associate Director, US Medical Affairs, Patient Access and Quality of Care at Gilead Sciences. Faculty collaborate on research and training in pharmaceutical sciences.
• Flatiron HealthcoreStrategic or Co-development PartnerBlythe Adamson serves as Affiliate Assistant Professor and Head of Outcomes Research and Evidence Generation, International at Flatiron Health. Research collaboration on real-world evidence and health outcomes.
• PATHcoreStrategic or Co-development PartnerDeb Atherly serves as Affiliate Assistant Professor and Global Head, Policy Access and Introduction, Center for Vaccine Innovation and Access at PATH. Collaboration on global health policy and vaccine access research.
• Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerMultiple faculty serve as affiliate members/investigators including Rodney JY Ho, Joanne Wang, and Carolyn Rutter. Collaborative research on cancer treatments, drug development, and health outcomes.
• UW Medicine (Health System)coreStrategic or Co-development PartnerSteve Fijalka serves as Chief Pharmacy Officer for UW Medicine while Associate Dean. Clinical practice partnerships with Harborview, UW Medical Center, and other UW Medicine facilities for experiential education and research.
• Kaiser Permanente Washington Research InstitutesecondaryStrategic or Co-development PartnerRyan Hansen serves as Affiliate Investigator at Kaiser Permanente Washington Research Institute. Collaborative research on comparative effectiveness, health services, and pharmaceutical policy.
• CurtasecondaryStrategic or Co-development PartnerLisa Bloudek serves as Partner and CEO of Curta, and Elizabeth Brouwer as Director of Real-World Evidence. Collaboration on health economics and outcomes research.
• Boston Consulting GroupsecondaryStrategic or Co-development PartnerJens Grueger serves as Affiliate Professor and Director and Partner at Boston Consulting Group, bringing industry expertise to health economics research.
• Accipiter BiosciencessecondaryStrategic or Co-development PartnerWilliam Canestaro serves as Chief Strategy Officer/Chief Operations Officer of Accipiter Biosciences. Technology transfer and commercialization collaboration.
• WE-REACH (Washington Entrepreneurial Research Evaluation and Commercialization Hub)coreStrategic or Co-development PartnerMulti-institutional hub for translating research discoveries into commercial products, with Rodney JY Ho as Executive Director. Partnership supports faculty entrepreneurship and technology commercialization.
• Washington State Pharmacy AssociationcoreChannel Partner/ Reseller/ DistributorOngoing partnership for continuing education credit provision. The Katterman Memorial Lecture provides CE credits for practitioners, free for Pharmacy Alumni Association members.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regional players

• Oregon State University College of Pharmacy: Pacific Northwest pharmacy school with overlapping applicant pool, preceptor networks, and continuing-education partnerships. Regional peer rather than national competitor.

Direct peers

• University of Wisconsin–Madison School of Pharmacy: Major public-university pharmacy school with parallel PharmD/PhD portfolio and significant research output in drug discovery and pharmacokinetics. Direct competitor for faculty and graduate applicants.
• University of Maryland School of Pharmacy: Top-ranked pharmacy school with parallel PharmD/PhD portfolio and strong pharmacoeconomics research (PATIENTS program). Direct peer competing for federal funding and graduate students.
• University of Michigan College of Pharmacy: Major public-university pharmacy school with parallel PharmD/PhD portfolio spanning medicinal chemistry, pharmaceutics, and health services research. Direct competitor for faculty, NIH funding, and top graduate applicants.
• University of North Carolina Eshelman School of Pharmacy: Closely matched peer offering PharmD, PhD in pharmaceutical sciences, and PharmD-MBA dual degree with strong industry and translational research ties. Competes head-to-head for research rankings and pharmaceutical-sciences faculty.
• University of Pittsburgh School of Pharmacy: Research-intensive pharmacy school with similar PharmD/PhD structure and notable pharmaceutical sciences output. Comparable in scale, public-university setting, and translational research focus.
• University of California, San Francisco School of Pharmacy: Top-tier peer U.S. pharmacy school offering PharmD and PhD programs with deep research emphasis in drug discovery, pharmacokinetics, and health economics. Comparable in mission, scale, and research portfolio to UW School of Pharmacy.
• University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences: PharmD and pharmaceutical-sciences PhD programs with deep industry and regulatory affairs ties in Los Angeles. Comparable in offering pharmaceutical regulatory expertise and translational research.
• Ohio State University College of Pharmacy: Large public-university pharmacy college offering parallel PharmD, PhD, and MS programs with strength in pharmacology and translational research. Direct peer in scale and structure.
• University of Minnesota College of Pharmacy: Public Big Ten pharmacy school with comparable depth in pharmaceutics, medicinal chemistry, and pharmacy practice, including an ambulatory care residency program. Competes for NIH funding and PharmD applicants in the upper Midwest.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/UW_Pharmacy
• YouTubeyoutube.com/user/UWPharmacySchool
• Facebookfacebook.com/UWSOP
• LinkedInlinkedin.com/company/uwsop
• Instagraminstagram.com/uw_pharmacy

Revenue estimate

Valuation estimate

Number of profiles

Profiles20 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Washington School of Pharmacy